Skip to content

BillionToOne, Inc. BLLN Accrued Compensation

Accrued Compensation at other companies

Guardant Health logo
Guardant HealthGH
$91.33M+43.4%
Exelixis logo
ExelixisEXEL
$87.51M-2.5%
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
Jazz Pharmaceuticals logo
Jazz PharmaceuticalsJAZZ

Other financials

Income statement

See full
Revenue$108.4M+83.8%
Gross profit$79.1M+108%
Operating income$17.8M+870%
Net income$18.0M+551%
EPS (diluted)$0.34+187%

Balance sheet

See full
Cash & equivalents$537.5M+181%
Total debt$144.2M
Total equity$505.6M+300%
Total assets$700.7M

Cash flow

See full
Operating cash flow$15.4M+488%
CapEx$4.5M+90.5%
Free cash flow$11.0M+3,842%

Valuation

See full
Market cap$4.84B

Profitability

See full
Gross margin70.4%
Operating margin-96.9%
Net margin8.4%
FCF margin-83.4%

Returns & leverage

See full
Debt / equity0.3×
Current ratio10.9×

Where this comes from

Reported directly by BillionToOne, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AccruedEmployeeBenefitsCurrent.

The official record: BillionToOne, Inc. ’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about BillionToOne, Inc. 's accrued compensation.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is BillionToOne, Inc. 's accrued compensation?
BillionToOne, Inc. (BLLN) reported accrued compensation of $18.28M in Q1 2026.
What does accrued compensation mean?
Employee wages, salaries, bonuses, commissions, and benefits earned but not yet paid as of the reporting date.